Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (582)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
162
2025
2990
11.590
Why?
Antibodies, Monoclonal
26
2024
460
6.150
Why?
Hematopoietic Stem Cell Transplantation
28
2024
580
3.320
Why?
Antineoplastic Agents
18
2024
1165
3.260
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
997
3.220
Why?
Humans
215
2025
50419
2.250
Why?
Thalidomide
24
2024
375
1.970
Why?
Monoclonal Gammopathy of Undetermined Significance
10
2024
112
1.850
Why?
Neoplasm Recurrence, Local
15
2024
622
1.780
Why?
Immunotherapy, Adoptive
9
2024
161
1.740
Why?
Killer Cells, Natural
8
2024
107
1.700
Why?
Transplantation, Autologous
26
2024
480
1.700
Why?
Gene Expression Profiling
27
2025
1020
1.640
Why?
Interleukin-6
12
2023
261
1.630
Why?
Middle Aged
77
2025
12579
1.580
Why?
Neoplasm Proteins
13
2022
320
1.560
Why?
Hematologic Neoplasms
3
2022
99
1.550
Why?
Prognosis
46
2025
1974
1.440
Why?
Aged
77
2025
9738
1.410
Why?
Antigens, Neoplasm
6
2014
148
1.400
Why?
Clinical Trials as Topic
13
2022
488
1.390
Why?
Stem Cell Transplantation
10
2022
179
1.320
Why?
B-Cell Maturation Antigen
9
2025
98
1.300
Why?
Gene Expression Regulation, Neoplastic
20
2022
831
1.240
Why?
Adult
57
2025
13561
1.220
Why?
Combined Modality Therapy
19
2024
640
1.220
Why?
Chromosomes, Human, Pair 1
9
2023
92
1.210
Why?
Male
87
2025
25866
1.180
Why?
Herpesvirus 8, Human
7
2021
97
1.170
Why?
Female
89
2025
27053
1.170
Why?
Antibodies, Bispecific
6
2025
88
1.170
Why?
Treatment Outcome
47
2024
5265
1.100
Why?
Boronic Acids
12
2013
182
1.080
Why?
Pyrazines
12
2013
187
1.080
Why?
Bone Marrow
18
2024
360
1.030
Why?
Proteasome Inhibitors
5
2024
104
1.020
Why?
Translocation, Genetic
9
2022
236
0.990
Why?
Immunotherapy
6
2024
234
0.970
Why?
Neoplasms, Second Primary
2
2024
74
0.950
Why?
Disease-Free Survival
24
2019
439
0.920
Why?
B-Lymphocytes
5
2024
171
0.890
Why?
Dexamethasone
14
2024
431
0.880
Why?
T-Lymphocytes, Cytotoxic
4
2014
63
0.860
Why?
Melphalan
9
2020
177
0.860
Why?
Cancer Vaccines
3
2010
80
0.840
Why?
Follow-Up Studies
26
2024
2231
0.830
Why?
Plasma Cells
11
2023
220
0.810
Why?
Hyperhidrosis
1
2022
2
0.800
Why?
Sweat
1
2022
7
0.800
Why?
Survival Rate
24
2020
906
0.780
Why?
Lymphoma, B-Cell
3
2022
49
0.770
Why?
Drug Approval
1
2022
47
0.760
Why?
Ehrlichia chaffeensis
1
2021
4
0.730
Why?
Patient Participation
1
2022
73
0.730
Why?
T-Lymphocytes
8
2024
325
0.730
Why?
Ehrlichiosis
1
2021
14
0.720
Why?
Cryosurgery
1
2021
36
0.720
Why?
Immunoglobulin Light Chains
3
2017
83
0.710
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
27
0.700
Why?
Embolization, Therapeutic
1
2021
87
0.680
Why?
Cell Proliferation
10
2023
980
0.670
Why?
Disease Progression
16
2023
825
0.660
Why?
Aged, 80 and over
21
2025
3233
0.660
Why?
Chromosomal Instability
1
2019
16
0.650
Why?
Membrane Proteins
3
2006
337
0.630
Why?
Neoplasms, Plasma Cell
3
2024
36
0.630
Why?
Survival Analysis
18
2024
658
0.620
Why?
Adrenal Cortex Hormones
2
2023
102
0.620
Why?
Immunologic Factors
2
2018
113
0.610
Why?
Epigenesis, Genetic
4
2023
371
0.600
Why?
Neoplasm, Residual
8
2022
161
0.600
Why?
Tumor Microenvironment
6
2024
221
0.600
Why?
Chromosome Aberrations
12
2023
279
0.590
Why?
Dendritic Cells
3
2014
135
0.580
Why?
POEMS Syndrome
1
2018
32
0.580
Why?
Atrial Fibrillation
2
2022
188
0.580
Why?
Thyroid Neoplasms
1
2019
109
0.560
Why?
Polymorphism, Single Nucleotide
3
2024
468
0.560
Why?
Prealbumin
2
2014
21
0.550
Why?
Antibodies, Monoclonal, Humanized
6
2023
224
0.540
Why?
Positron-Emission Tomography
7
2022
290
0.530
Why?
Receptors, Interleukin-6
2
2014
22
0.530
Why?
Cardiomyopathies
2
2014
119
0.500
Why?
Mutation
10
2022
1275
0.490
Why?
Risk Assessment
11
2025
1268
0.480
Why?
Osteolysis
4
2022
74
0.470
Why?
Immunotoxins
1
2014
6
0.450
Why?
Drug Resistance, Neoplasm
7
2024
315
0.450
Why?
Risk Factors
20
2025
3712
0.450
Why?
Recurrence
13
2024
657
0.450
Why?
Cytotoxicity, Immunologic
2
2012
57
0.440
Why?
Clonal Evolution
3
2020
56
0.440
Why?
Practice Guidelines as Topic
4
2023
473
0.430
Why?
Cyclophosphamide
5
2021
168
0.420
Why?
Amyloidosis
1
2014
79
0.420
Why?
Health Status
1
2015
298
0.410
Why?
Transplantation, Homologous
5
2017
146
0.410
Why?
Thrombocytopenia
3
2025
82
0.410
Why?
Fluorodeoxyglucose F18
6
2021
187
0.400
Why?
Genome-Wide Association Study
3
2024
163
0.390
Why?
Remission Induction
13
2021
208
0.390
Why?
Neutropenia
2
2023
116
0.380
Why?
Receptors, KIR
2
2008
12
0.380
Why?
Genetic Predisposition to Disease
3
2024
507
0.370
Why?
Bone Diseases
3
2021
96
0.360
Why?
Pyrimidines
2
2022
187
0.360
Why?
Dose-Response Relationship, Drug
8
2020
1369
0.360
Why?
Prospective Studies
9
2025
2378
0.360
Why?
Cytokines
3
2025
602
0.360
Why?
Azacitidine
1
2010
34
0.350
Why?
Benzamides
1
2010
50
0.350
Why?
Evolution, Molecular
2
2021
86
0.350
Why?
Histone Deacetylase Inhibitors
1
2010
56
0.340
Why?
C-Reactive Protein
6
2022
145
0.340
Why?
Prednisone
2
2021
101
0.330
Why?
Doxorubicin
6
2021
235
0.330
Why?
TOR Serine-Threonine Kinases
2
2020
76
0.320
Why?
Drug Administration Schedule
5
2015
373
0.320
Why?
Chromosome Deletion
5
2023
134
0.320
Why?
Quality of Life
1
2015
850
0.310
Why?
Vaccination
4
2022
275
0.310
Why?
Metaphase
4
2016
45
0.310
Why?
Pelvis
2
2021
66
0.310
Why?
Membrane Glycoproteins
2
2009
246
0.310
Why?
Lymph Nodes
4
2025
256
0.300
Why?
Animals
15
2024
13063
0.300
Why?
Paraproteinemias
3
2022
71
0.300
Why?
Disease Management
3
2025
179
0.300
Why?
Proportional Hazards Models
7
2024
416
0.300
Why?
Young Adult
8
2025
4075
0.290
Why?
Placebo Effect
2
2020
17
0.290
Why?
Fever
3
2025
112
0.290
Why?
Bone Neoplasms
4
2013
178
0.290
Why?
Adoptive Transfer
1
2007
29
0.290
Why?
Histocompatibility Antigens Class I
1
2007
46
0.280
Why?
CD8-Positive T-Lymphocytes
3
2024
127
0.280
Why?
Cytogenetic Analysis
5
2023
74
0.280
Why?
DNA Methylation
4
2023
548
0.270
Why?
Registries
4
2025
565
0.270
Why?
Boron Compounds
2
2024
19
0.270
Why?
Chromans
2
2024
35
0.270
Why?
Vincristine
3
2021
82
0.270
Why?
Cell Membrane
1
2007
247
0.260
Why?
Mice, SCID
6
2013
171
0.260
Why?
Glycine
2
2024
78
0.260
Why?
Angiogenesis Inhibitors
5
2010
183
0.260
Why?
Down-Regulation
1
2007
338
0.260
Why?
In Situ Hybridization, Fluorescence
5
2023
231
0.260
Why?
Neoplasm Staging
6
2024
738
0.250
Why?
Cell Line, Tumor
9
2023
1393
0.250
Why?
Mice
11
2024
5659
0.250
Why?
Chromosomes, Human, Pair 17
2
2017
34
0.250
Why?
Vitamin E
2
2024
78
0.240
Why?
Case-Control Studies
6
2024
1152
0.240
Why?
Transplantation Conditioning
5
2008
88
0.240
Why?
Bone Resorption
2
2022
301
0.240
Why?
Infusions, Intravenous
3
2015
212
0.240
Why?
Chromatin
2
2023
133
0.240
Why?
Connective Tissue Diseases
1
2025
17
0.240
Why?
Antibody Formation
1
2005
50
0.230
Why?
Immunoglobulins, Intravenous
1
2025
64
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Autoantibodies
1
2025
114
0.230
Why?
Time Factors
11
2021
2933
0.230
Why?
Flow Cytometry
4
2012
472
0.220
Why?
Monocytes
2
2020
130
0.220
Why?
Gene Expression
2
2018
605
0.220
Why?
High-Throughput Nucleotide Sequencing
3
2022
162
0.220
Why?
Cell Cycle Proteins
2
2022
163
0.210
Why?
Ubiquitin-Protein Ligases
1
2024
93
0.210
Why?
Blotting, Western
3
2015
575
0.210
Why?
Signal Transduction
6
2021
1608
0.210
Why?
Proteasome Endopeptidase Complex
3
2011
116
0.210
Why?
Epstein-Barr Virus Infections
2
2020
30
0.210
Why?
Radiation-Protective Agents
1
2024
72
0.210
Why?
Integrin beta Chains
1
2023
13
0.210
Why?
Integrins
1
2023
29
0.210
Why?
Cross-Sectional Studies
3
2023
1601
0.200
Why?
Double-Blind Method
2
2015
710
0.200
Why?
Sweating
1
2022
7
0.200
Why?
Hematopoietic Stem Cells
2
2022
197
0.200
Why?
Consensus
2
2020
159
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.200
Why?
Kaplan-Meier Estimate
10
2016
462
0.190
Why?
DNA, Intergenic
1
2022
5
0.190
Why?
Proteomics
3
2021
313
0.190
Why?
Tumor Cells, Cultured
4
2013
453
0.190
Why?
Tumor Suppressor Protein p53
2
2017
212
0.190
Why?
Immunoconjugates
1
2022
37
0.190
Why?
Receptors, Antigen, T-Cell
1
2022
49
0.190
Why?
United States
4
2022
5005
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
United States Food and Drug Administration
1
2022
91
0.190
Why?
Influenza, Human
1
2022
86
0.190
Why?
Chromosomes, Human, Pair 14
3
2020
66
0.180
Why?
Mediastinum
1
2021
21
0.180
Why?
Receptors, Glucocorticoid
2
2012
31
0.180
Why?
Apoptosis
5
2018
1092
0.180
Why?
Phosphatidylinositol 3-Kinases
2
2019
139
0.180
Why?
Ubiquitination
1
2021
42
0.180
Why?
Retrospective Studies
10
2025
6274
0.180
Why?
Axilla
1
2021
92
0.180
Why?
Alleles
3
2021
252
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
82
0.180
Why?
Multiple Organ Failure
1
2021
48
0.180
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
90
0.180
Why?
Adolescent
7
2025
6453
0.180
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.180
Why?
Salvage Therapy
6
2013
137
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
124
0.180
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.180
Why?
Rare Diseases
1
2020
43
0.170
Why?
Interferon-gamma
3
2014
175
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Radiopharmaceuticals
4
2021
202
0.170
Why?
Cell Cycle
1
2021
227
0.170
Why?
Longitudinal Studies
5
2024
732
0.170
Why?
Myelodysplastic Syndromes
2
2013
78
0.170
Why?
Interferon Type I
1
2020
23
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
32
0.170
Why?
Genomics
4
2023
238
0.170
Why?
Research Design
2
2020
348
0.170
Why?
Multivariate Analysis
8
2021
583
0.170
Why?
Gene Amplification
1
2019
56
0.160
Why?
DNA
1
2023
534
0.160
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
Measles virus
1
2019
8
0.160
Why?
Health Status Disparities
1
2022
201
0.160
Why?
Data Collection
1
2020
280
0.160
Why?
Measles
1
2019
7
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Immunohistochemistry
2
2015
955
0.160
Why?
Oncolytic Virotherapy
1
2019
15
0.160
Why?
Biopsy
5
2018
588
0.160
Why?
Patient Safety
1
2020
102
0.160
Why?
Sirolimus
1
2019
61
0.160
Why?
Cell Differentiation
6
2022
640
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Healthcare Disparities
1
2022
280
0.150
Why?
Proto-Oncogene Proteins c-akt
1
2019
155
0.150
Why?
Precancerous Conditions
2
2010
83
0.150
Why?
Evidence-Based Medicine
2
2018
254
0.150
Why?
Syndrome
1
2019
236
0.150
Why?
Graft vs Host Disease
4
2007
85
0.150
Why?
MafB Transcription Factor
1
2018
9
0.150
Why?
Spleen
1
2019
169
0.150
Why?
Genomic Instability
2
2016
90
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Immunomodulation
1
2018
35
0.150
Why?
Chemokines
1
2018
75
0.150
Why?
Plasma
1
2018
45
0.140
Why?
Myeloablative Agonists
2
2008
32
0.140
Why?
Hematopoietic Stem Cell Mobilization
2
2008
58
0.140
Why?
Genes, Neoplasm
2
2015
27
0.140
Why?
Osteoclasts
3
2022
427
0.140
Why?
Models, Biological
2
2018
717
0.140
Why?
Magnetic Resonance Imaging
5
2013
1546
0.140
Why?
Adipocytes
1
2018
126
0.140
Why?
Gene Dosage
2
2015
73
0.140
Why?
Gene Rearrangement
1
2018
63
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Communication
1
2019
256
0.140
Why?
Heterozygote
2
2014
83
0.140
Why?
Protein-Tyrosine Kinases
2
2018
85
0.140
Why?
HLA-A Antigens
2
2007
10
0.130
Why?
Calcification, Physiologic
1
2017
40
0.130
Why?
Drug Therapy, Combination
1
2018
387
0.130
Why?
Oligonucleotide Array Sequence Analysis
5
2010
400
0.130
Why?
Gene Frequency
2
2013
93
0.130
Why?
Transcriptome
4
2020
314
0.130
Why?
Syndecan-1
4
2021
73
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Critical Illness
1
2018
302
0.130
Why?
Lymphocyte Activation
2
2017
169
0.130
Why?
Confidence Intervals
2
2014
155
0.120
Why?
Tumor Burden
3
2020
130
0.120
Why?
Immunity, Innate
1
2016
104
0.120
Why?
Erythrocyte Indices
1
2015
7
0.120
Why?
Biomarkers, Pharmacological
2
2012
25
0.120
Why?
DNA Copy Number Variations
3
2022
109
0.120
Why?
Coculture Techniques
2
2013
140
0.120
Why?
Hemoglobins
2
2013
112
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.110
Why?
Hematologic Diseases
1
2014
21
0.110
Why?
Half-Life
1
2014
86
0.110
Why?
International Cooperation
1
2014
46
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
227
0.110
Why?
Iron
1
2015
120
0.110
Why?
Fatigue
1
2015
127
0.110
Why?
Area Under Curve
1
2014
179
0.110
Why?
Antibodies
2
2024
151
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Reference Values
1
2014
302
0.110
Why?
ROC Curve
1
2014
223
0.110
Why?
Severity of Illness Index
2
2014
976
0.110
Why?
Emotions
1
2015
167
0.110
Why?
Disease Models, Animal
2
2016
1431
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
73
0.110
Why?
Renal Insufficiency
2
2021
109
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.110
Why?
Administration, Metronomic
1
2013
7
0.110
Why?
Inflammation Mediators
1
2014
110
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Cisplatin
4
2013
283
0.110
Why?
Macaca mulatta
2
2024
97
0.100
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.100
Why?
Central Nervous System Neoplasms
1
2013
61
0.100
Why?
beta Catenin
1
2013
96
0.100
Why?
Venous Thrombosis
2
2004
86
0.100
Why?
Oligopeptides
1
2013
94
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
13
0.100
Why?
Leukemia
1
2013
65
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Mental Health
1
2015
225
0.100
Why?
Edema
2
2025
69
0.100
Why?
Cell Survival
2
2020
587
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
72
0.100
Why?
Maintenance Chemotherapy
1
2012
48
0.100
Why?
Pain
1
2015
386
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
180
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
200
0.100
Why?
Models, Genetic
2
2016
166
0.100
Why?
Interleukin-2
1
2012
70
0.100
Why?
Cell Movement
1
2013
244
0.100
Why?
Mice, Inbred NOD
1
2012
89
0.100
Why?
Immunoenzyme Techniques
1
2012
140
0.090
Why?
Hemangioma
1
2013
83
0.090
Why?
Soft Tissue Neoplasms
1
2012
54
0.090
Why?
Genotype
1
2013
525
0.090
Why?
Arkansas
5
2021
1974
0.090
Why?
Immunoglobulin G
2
2025
188
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
45
0.090
Why?
Chemokine CXCL13
2
2022
5
0.090
Why?
Models, Statistical
2
2014
224
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
56
0.090
Why?
Mutation Rate
2
2021
35
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
CD40 Ligand
1
2010
14
0.090
Why?
Hypersensitivity, Delayed
1
2010
18
0.090
Why?
Secondary Prevention
1
2010
80
0.090
Why?
Interleukin-4
1
2010
42
0.090
Why?
Up-Regulation
4
2018
446
0.090
Why?
HIV Seropositivity
1
2010
27
0.090
Why?
Eukaryotic Initiation Factor-2
1
2010
13
0.080
Why?
Immunity, Cellular
1
2010
68
0.080
Why?
Adjuvants, Immunologic
1
2010
52
0.080
Why?
Cell Line
2
2013
997
0.080
Why?
Cells, Cultured
3
2013
1563
0.080
Why?
Ovarian Neoplasms
1
2014
449
0.080
Why?
Etoposide
2
2007
77
0.080
Why?
Placenta
1
2011
134
0.080
Why?
Transplantation, Heterologous
1
2009
73
0.080
Why?
Radiography
4
2012
482
0.080
Why?
Hospitalization
2
2024
677
0.080
Why?
Polymerase Chain Reaction
1
2010
447
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.080
Why?
Transcription Factors
2
2023
561
0.080
Why?
Liver Neoplasms
1
2012
321
0.080
Why?
Bone and Bones
3
2021
481
0.080
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Haplotypes
1
2008
83
0.070
Why?
Immunoglobulin lambda-Chains
1
2008
14
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2008
63
0.070
Why?
Cytogenetics
1
2008
21
0.070
Why?
Gene Deletion
1
2009
260
0.070
Why?
Neoplastic Stem Cells
1
2009
97
0.070
Why?
Receptors, Immunologic
1
2008
35
0.070
Why?
Ligands
1
2008
203
0.070
Why?
Osteogenesis
1
2011
354
0.070
Why?
Twins
1
2007
20
0.070
Why?
Busulfan
1
2007
19
0.070
Why?
Diphosphonates
1
2008
90
0.070
Why?
Herpesviridae Infections
2
2019
54
0.070
Why?
Immunophenotyping
1
2007
106
0.070
Why?
Leukocytes, Mononuclear
1
2007
118
0.070
Why?
Caspases
2
2018
103
0.070
Why?
Antimetabolites
1
2006
13
0.070
Why?
Skin Neoplasms
1
2012
492
0.070
Why?
Creatinine
1
2007
142
0.070
Why?
Blood Proteins
1
2007
83
0.070
Why?
Antibodies, Neoplasm
1
2006
28
0.070
Why?
Immunosuppressive Agents
1
2008
227
0.070
Why?
Graft vs Leukemia Effect
1
2006
3
0.070
Why?
Cohort Studies
3
2020
1451
0.060
Why?
Chromosome Banding
1
2006
18
0.060
Why?
Plasmacytoma
1
2006
42
0.060
Why?
MicroRNAs
1
2010
345
0.060
Why?
Amiloride
1
2005
8
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Bone Marrow Transplantation
2
2022
135
0.060
Why?
Imaging, Three-Dimensional
2
2017
151
0.060
Why?
Child
3
2025
6931
0.060
Why?
Sensitivity and Specificity
1
2007
855
0.060
Why?
Japan
1
2025
26
0.060
Why?
Predictive Value of Tests
3
2018
924
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
29
0.060
Why?
Tomography, X-Ray Computed
2
2023
1163
0.060
Why?
Autoantigens
1
2025
49
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
3
0.060
Why?
Piperidones
1
2024
6
0.060
Why?
Enoxaparin
1
2004
31
0.060
Why?
Telomere
1
2024
35
0.060
Why?
Retreatment
1
2024
56
0.060
Why?
NF-kappa B
2
2018
306
0.060
Why?
Ferritins
1
2024
30
0.050
Why?
Morpholines
1
2024
64
0.050
Why?
Cost of Illness
1
2024
115
0.050
Why?
Neoplasms
1
2014
1248
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
78
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
49
0.050
Why?
Fibroblasts
1
2005
338
0.050
Why?
Epidemiologic Methods
3
2008
47
0.050
Why?
DNA, Neoplasm
2
2020
144
0.050
Why?
Gene Silencing
2
2016
114
0.050
Why?
Cluster Analysis
3
2010
209
0.050
Why?
Cell Communication
1
2023
70
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
49
0.050
Why?
Geography
1
2022
60
0.050
Why?
Phenotype
1
2025
736
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Whole-Body Irradiation
1
2022
131
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
19
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Quantitative Trait Loci
1
2022
42
0.050
Why?
Primary Cell Culture
1
2022
60
0.050
Why?
Patient Selection
1
2023
257
0.050
Why?
Risk
2
2014
325
0.050
Why?
Phylogeny
1
2022
195
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
36
0.050
Why?
Anticoagulants
1
2004
254
0.050
Why?
Age of Onset
2
2013
109
0.050
Why?
Child, Preschool
2
2020
3953
0.050
Why?
Polymorphism, Genetic
1
2022
177
0.050
Why?
Rabbits
2
2013
369
0.050
Why?
RANK Ligand
1
2022
186
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Transcriptional Activation
1
2021
120
0.040
Why?
Base Sequence
1
2022
622
0.040
Why?
Fibrosis
1
2021
181
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Spatio-Temporal Analysis
1
2020
8
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Repressor Proteins
1
2022
149
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Genome, Human
1
2021
108
0.040
Why?
Protein Kinase Inhibitors
1
2022
204
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Genetic Loci
1
2020
45
0.040
Why?
Mice, Transgenic
1
2021
537
0.040
Why?
Genetic Variation
1
2020
197
0.040
Why?
False Negative Reactions
1
2019
29
0.040
Why?
DNA Mutational Analysis
1
2020
175
0.040
Why?
Neoplasm Invasiveness
1
2020
269
0.040
Why?
Incidence
2
2013
1027
0.040
Why?
Europe
1
2019
80
0.040
Why?
Herpesvirus 4, Human
1
2019
37
0.040
Why?
Communicable Disease Control
1
2019
35
0.040
Why?
RNA, Messenger
2
2016
1085
0.040
Why?
Computational Biology
1
2020
194
0.040
Why?
Genome, Viral
1
2019
73
0.040
Why?
beta 2-Microglobulin
2
2009
37
0.040
Why?
DNA, Viral
1
2019
134
0.040
Why?
Virus Diseases
1
2019
42
0.040
Why?
Fibrinogen
1
2018
33
0.040
Why?
Immunoglobulin A
1
2018
44
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
20
0.040
Why?
Histones
1
2020
294
0.040
Why?
Bone Marrow Cells
2
2014
195
0.040
Why?
DNA-Binding Proteins
1
2021
410
0.040
Why?
Platelet Count
2
2008
65
0.040
Why?
Promoter Regions, Genetic
1
2020
455
0.040
Why?
Pathology, Molecular
1
2018
22
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
46
0.040
Why?
Oncogene Proteins, Fusion
1
2018
57
0.040
Why?
Data Interpretation, Statistical
2
2010
162
0.040
Why?
Databases, Factual
2
2013
676
0.040
Why?
Kidney Function Tests
1
2017
52
0.030
Why?
False Positive Reactions
1
2017
59
0.030
Why?
Glomerular Filtration Rate
1
2017
119
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
182
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
18
0.030
Why?
Internationality
1
2017
39
0.030
Why?
Amino Acid Sequence
1
2018
575
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
77
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
Glycolysis
1
2016
69
0.030
Why?
Proteolysis
1
2016
96
0.030
Why?
Chromosome Mapping
2
2006
143
0.030
Why?
Enzyme Activation
1
2016
268
0.030
Why?
Prevalence
1
2019
967
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Phosphorylation
1
2016
520
0.030
Why?
Kidney Diseases
1
2017
213
0.030
Why?
Myocardium
1
2017
443
0.030
Why?
Asymptomatic Diseases
1
2014
38
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Capsid
1
2014
2
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
HIV-1
1
2014
50
0.030
Why?
Homozygote
1
2013
57
0.030
Why?
Cerebrospinal Fluid
1
2013
32
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Diagnosis, Differential
1
2017
1029
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Acrylamides
1
2013
7
0.030
Why?
Receptors, CXCR4
1
2013
28
0.030
Why?
Dependovirus
1
2014
102
0.030
Why?
Niacinamide
1
2013
23
0.030
Why?
Amides
1
2013
34
0.030
Why?
NAD
1
2013
41
0.030
Why?
Enzyme Induction
1
2013
78
0.030
Why?
Nitriles
1
2013
52
0.030
Why?
Sirtuin 1
1
2013
28
0.030
Why?
Chemokine CXCL12
1
2013
33
0.030
Why?
Gene Knockdown Techniques
1
2013
104
0.030
Why?
Transplantation Chimera
2
2003
14
0.030
Why?
RNA, Small Interfering
1
2013
208
0.020
Why?
Infant
1
2020
3648
0.020
Why?
Piperidines
1
2013
97
0.020
Why?
Induction Chemotherapy
1
2012
59
0.020
Why?
Lymphocyte Count
1
2011
19
0.020
Why?
HIV Infections
1
2016
347
0.020
Why?
Acute Disease
1
2013
374
0.020
Why?
Chemokine CXCL10
1
2011
19
0.020
Why?
Antibodies, Neutralizing
1
2011
62
0.020
Why?
Sex Factors
1
2013
718
0.020
Why?
Pharmacogenetics
1
2011
50
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
25
0.020
Why?
Enzyme Inhibitors
1
2013
369
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
46
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
47
0.020
Why?
Microarray Analysis
1
2010
69
0.020
Why?
International Classification of Diseases
1
2010
64
0.020
Why?
Argonaute Proteins
1
2010
11
0.020
Why?
RNA-Binding Proteins
1
2011
116
0.020
Why?
Oligonucleotides
1
2010
75
0.020
Why?
Polyploidy
1
2009
11
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
61
0.020
Why?
Neoplasm Metastasis
1
2009
230
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
34
0.020
Why?
Polyethylene Glycols
1
2008
84
0.020
Why?
Serum Albumin
1
2008
57
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
567
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
210
0.020
Why?
Age Distribution
1
2007
172
0.020
Why?
Recombinant Proteins
1
2008
477
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
Why?
Multigene Family
1
2006
46
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
35
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
44
0.020
Why?
Proteoglycans
1
2006
81
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
180
0.020
Why?
Brain
1
2013
1318
0.020
Why?
Survivors
1
2006
126
0.010
Why?
Pregnancy
1
2011
2444
0.010
Why?
Probability
1
2003
163
0.010
Why?
Lymphocyte Transfusion
1
2003
12
0.010
Why?
Administration, Oral
1
2003
438
0.010
Why?
Tissue Donors
1
2003
121
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description